Search Results for "prepared"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for prepared. Results 81 to 90 of 236 total matches.

Alpha1-Proteinase Inhibitor for Alpha1-Antitrypsin Deficiency

   
The Medical Letter on Drugs and Therapeutics • Mar 11, 1988  (Issue 761)
reactions occurred, including fever, dizziness, and transient leukocytosis. The product is prepared ...
Human alpha1-proteinase inhibitor (Prolastin Cutter), possibly better known as alpha1-antitypsin (ATT), is now available in the USA for replacement therapy in patients with emphysema who have a congential deficiency of the protein.
Med Lett Drugs Ther. 1988 Mar 11;30(761):29-30 |  Show IntroductionHide Introduction

Alglucerase For Gaucher's Disease

   
The Medical Letter on Drugs and Therapeutics • Aug 23, 1991  (Issue 851)
of the glycoprotein enzyme glucocerebrosidase prepared from human placenta, was recently approved by the US Food ...
(Ceredase - Genzyme) a modified form of the glycoprotein enzyme glucocerebrosidase prepared from human placenta, was recently approved by the US Food and Drug Administration as an 'orphan drug' for treatment of patients with the non-neurologic form of Gaucher's disease (Type 1).
Med Lett Drugs Ther. 1991 Aug 23;33(851):82 |  Show IntroductionHide Introduction

Ketoconazole Shampoo For Dandruff

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 1994  (Issue 927)
Letter 36:16, 1994) and as a topical preparation for fungal skin infections, is also available ...
Ketoconazole (Nizoral - Janssen), an imidazole antifungal drug widely used in a tablet formulation for treatment of systemic fungal infections (Medical Letter 36:16, 1994) and as a topical preparation for fungal skin infections, is also available as a shampoo for treatment of seborrheic dandruff. The shampoo is sold only by prescription.
Med Lett Drugs Ther. 1994 Jul 22;36(927):68 |  Show IntroductionHide Introduction

Intraurethral Alprostadil for Impotence

   
The Medical Letter on Drugs and Therapeutics • Mar 28, 1997  (Issue 997)
preparation. Whether penile fibrosis could develop remains to be determined. Some female partners of men ...
The prostaglandin alprostadil injected into the corpus cavernosum (Caverject - Upjohn) can produce an erection in some men with erectile dysfunction (Medical Letter, 37:83, 1995). Now a pellet (microsuppository) formulation has become available for intraurethral administration of alprostadil (MUSE [Medicated Urethral System for Erection] - Vivus). It is marketed in a sterile foil pouch containing a pellet 1.4 mm in diameter and 3 or 6 mm long within the stem of a hollow applicator, which is inserted 3 cm deep into the urethra. Pressing a button pushes the pellet into the urethra.
Med Lett Drugs Ther. 1997 Mar 28;39(997):32 |  Show IntroductionHide Introduction

Saw Palmetto for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Feb 12, 1999  (Issue 1046)
, ethanol and carbon dioxide have been used in various preparations (FC Lowe and JC Ku, Urology, 48:12 ...
Saw palmetto, an "herbal supplement,"is now being heavily promoted to the general public for treatment of urinary symptoms related to prostatic enlargement. It has not been approved for any use by the FDA.
Med Lett Drugs Ther. 1999 Feb 12;41(1046):18 |  Show IntroductionHide Introduction

Rabies Vaccine

   
The Medical Letter on Drugs and Therapeutics • Dec 28, 1990  (Issue 834)
, 37:217, 1988). In some industrial countries, rabies vaccines may be prepared using duck, monkey ...
Human rabies continues to be rare in the USA, but animal rabies is becoming more common. An animal epizootic in the mid-Atlantic states, involving especially raccoons, has recently spread into the northeastern states.
Med Lett Drugs Ther. 1990 Dec 28;32(834):117-8 |  Show IntroductionHide Introduction

Alpha-Galactosidase to Prevent Gas

   
The Medical Letter on Drugs and Therapeutics • Apr 02, 1993  (Issue 893)
), and all three enzymes represent only a small fraction of the total Aspergillus protein in the preparation. Five ...
The enzyme alpha-galactosidase (Beano - AkPharma), derived from a mold and classified as a food, is sold without presecription in pharmacies and food stores. The manufacturer recommends taking the anzyme to decrease intestinal gas producted by eating the high-fiber diets now widely recommended in the USA.
Med Lett Drugs Ther. 1993 Apr 2;35(893):29-30 |  Show IntroductionHide Introduction

Glucosamine for Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • Sep 26, 1997  (Issue 1010)
are taking glucosamine has not detected any adverse effects. PREPARATIONS — Glucosamine is available ...
The Medical Letter has received many inquiries about use of glucosamine, a basic constituent of articular cartilage glycosaminoglycans, for treatment of arthritis. A recently published book (The Arthritis Cure), several television news shows, and articles in The New York Times have suggested it may be effective for treatment of osteoarthritis. Glucosamine is sold as a 'dietary supplement' in the USA.
Med Lett Drugs Ther. 1997 Sep 26;39(1010):91-2 |  Show IntroductionHide Introduction

Olopatadine for Allergic Conjunctivitis

   
The Medical Letter on Drugs and Therapeutics • Nov 21, 1997  (Issue 1014)
prepared by the manufacturer, the drug was tested in 278 subjects by placing the drug in one eye ...
Olopatadine hydrochloride (Patanol - Alcon), a propilidinedibenzoxypin derivative, has recently been marketed in a 0.1% ophthalmic solution for prevention of itching due to allergic conjunctivitis in adults and children more than three years old. It is the first drug for this indication that both inhibits mast cell degranulation and is a selective histamine H1 receptor antagonist (NA Sharif et al, J Pharmacol Exp Ther, 278:1252, 1996).
Med Lett Drugs Ther. 1997 Nov 21;39(1014):108-9 |  Show IntroductionHide Introduction

Nonstandard Uses of Chelation Therapy

   
The Medical Letter on Drugs and Therapeutics • Sep 20, 2010  (Issue 1347)
or legally marketable for any purpose, but some compounding pharmacies still prepare and sell it. COSTS ...
Chelation therapy involves oral administration, intravenous infusion or intramuscular injection of drugs that increase excretion of heavy metals. The Medical Letter’s last article on this subject found no evidence that it was effective for treatment of cardiovascular disease. Since then, off-label use of chelation therapy has expanded to include treating children with autism and adults with Alzheimer’s disease, cancer and other chronic diseases.

Click here to view the free full article.
Med Lett Drugs Ther. 2010 Sep 20;52(1347):75-6 |  Show IntroductionHide Introduction